![]() | Only 14 pages are availabe for public view |
Abstract Direct myocardial revascularization with coronary artery bypass grafting (CABG) has become one of the most commonly performed operations during the past 20 years and has proved to relieve angina in more than 85% to 90% of the patients (Acinapura et a!., 1989). The use of saphenous vein grafts (SVGs) was initially popularized, and it was hoped that long-term patency and clinical relief could be achieved. However, it has become clear since that the initial success is jeopardized by progression of atherosclerosis in the native circulation and , more importantly, by its development in SVGs, as shown by serial angiographic studies (Bical et a!., 1980 and Bourassa, 1983). As a result, more attention has been paid to dietary and pharmacologic control of hyperlipidemia, and the internal thoracic artery (IT A) has became the conduit of choice for CABG after many studies confirmed the long-term patency of ITA compared to SVGs. Up to 5 postoperative years, there is a 10-15% difference in patency rates, with 95% of ITA grafts patent, compared with 80-85% of vein grafts. However, more than 5 years after the operation, the attrition rate of venous |